Drug Trial News

RSS

Effectiveness of grief counselling to prevent complicated grief among families bereaved by suicide

A grief counselling programme for families bereaved by suicide does not reduce grief or depression, but may help to prevent perceptions of blame among close relatives and spouses, finds a study published on bmj.com today.

20 Apr 2007

Viventia Biotech announces results of Proxinium antibody in combinaton with chemotherapy and radiation

Viventia Biotech has announced results of in vitro cytotoxicity and in vivo pharmacokinetic studies conducted to evaluate the potential for combining its phase III anti-cancer antibody therapeutic, Proxinium, with first-line standard of care therapy for squamous cell carcinoma of the head & neck (SCCHN).

19 Apr 2007

First large-scale study to assess treatment for prescription drug addiction

UCSF is launching a new study to evaluate treatments for addiction to prescription painkillers and has openings for patients to enroll.

19 Apr 2007

Switching to a low-fat diet can bring on stress

Changing one's diet to lose weight is often difficult. There may be physical and psychological effects from a changed diet that reduce the chances for success.

19 Apr 2007

Stem cells decrease ischemic injury and restore brain function

This is the impressive result of a study carried out by a group of researchers coordinated by Dr. Maria Grazia De Simoni of the Mario Negri Institute in Milan, Italy in cooperation with the Istituto Neurologico Besta (Milan) and the University of Lausanne.

19 Apr 2007

Steroids for acute sinusitis

Every year, nearly 37 million Americans suffer from the sinus pressure, nasal congestion, cough and postnasal drip that accompany sinusitis.

19 Apr 2007

Standard long-acting insulin as good as newer medications

An older type of long-acting insulin is as effective in treating type 2 diabetes as newer and more expensive kinds, according to the results of a recent systematic review.

19 Apr 2007

Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults

A new review suggests that asthma treatment based on tests of fluid coughed up from the lungs could reduce the frequency and severity of flare-ups in adult asthma patients.

19 Apr 2007

Cigarette smoking status can be used as a clinical indicator for alcohol misuse

Where there is cigarette smoking there is probably misuse of alcohol too, according to a study by Yale School of Medicine researchers in the Archives of Internal Medicine.

19 Apr 2007

Wholegrain oats may reduce risk factors for coronary heart disease

Trials lasting 4 to 8 weeks indicate that including wholegrain oats in your diet may lower total and low-density lipoprotein cholesterol.

19 Apr 2007

Fourteen and fifteen year olds in Northern Ireland are using cannabis daily

Research from Queen's University Belfast has found that one in ten school children who had reported using cannabis at least once had now become daily users.

19 Apr 2007

Prazosin shows promise for post traumatic stress disorder sleep disturbances

For sufferers of Post Traumatic Stress Disorder (PTSD), sleep disturbances are among the most treatment-resistant symptoms and can lead to drug and alcohol abuse and even suicide.

19 Apr 2007

Protalix BioTherapeutics receives FDA approval to initiate a phase III trial of prGCD

Protalix BioTherapeutics, Inc. has announced that it has received written notice from the United States Food and Drug Administration (FDA) that it may initiate a Phase III clinical trial in the United States of its lead product candidate, prGCD, a proprietary plant cell expressed recombinant form of human Glucocerebrosidase (GCD), for the treatment of Gaucher Disease, a lysosomal storage disorder in humans.

19 Apr 2007

Placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms

All physicians involved in the treatment of PBS/IC understand that the placebo effect likely plays a major role in treatment, and is important when evaluating drug trials.

19 Apr 2007

New automated test for gene mutations causing fragile X syndrome

A new automated test could enable population screening to identify carriers of the gene mutations causing fragile X syndrome (FXS), the most common inherited form of mental retardation, reports a study in the April issue of Genetics in Medicine, published by the American College of Medical Genetics and Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

19 Apr 2007

Jefferson participates in global study to extend effectiveness of drug for Parkinson's

After Parkinson's disease patients use the drug levodopa or L-dopa for several years as a treatment for restoring the cellular communication that controls muscle movement by replacing lost dopamine, they begin to experience motor complications that include a shortened response to each dose of L-dopa.

19 Apr 2007

Genta Incorporated announces phase 3 trial of Genasense in patients with advanced melanoma

Genta Incorporated has announced that the Company will conduct a new randomized controlled Phase 3 trial of its lead anticancer product, Genasense (oblimersen sodium) Injection, in patients with advanced melanoma.

19 Apr 2007

The true value of herbs and spices on health

Compelling evidence that herbs and spices found prevalent in many popular dishes can help ward off disease remains elusive but, according to the latest issue of Food Technology magazine, some small clinical trials raise the question of whether some positive health influence exists.

19 Apr 2007

Drains increase harm without providing any benefit for patients undergoing open cholecystectomy

Cholecystectomy is the term used to describe the surgical removal of a gallbladder. It is performed mainly as a treatment for chronic gallstones. Although many operations are now carried out by laparoscopy, some are still done by open surgery. In these operations there is an ongoing debate about whether drains should be used.

19 Apr 2007

Study evaluates whether dipyrone is effective and safe for acute primary headaches

The controversial drug dipyrone can treat acute headaches, but patients should be warned of the risk of potentially serious blood disorders (or "dyscrasias"), concluded a Cochrane Review team.

19 Apr 2007

Drug Trial News

Effectiveness of grief counselling to prevent complicated grief among families bereaved by suicide

Viventia Biotech announces results of Proxinium antibody in combinaton with chemotherapy and radiation

First large-scale study to assess treatment for prescription drug addiction

Switching to a low-fat diet can bring on stress

Stem cells decrease ischemic injury and restore brain function

Steroids for acute sinusitis

Standard long-acting insulin as good as newer medications

Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults

Cigarette smoking status can be used as a clinical indicator for alcohol misuse

Wholegrain oats may reduce risk factors for coronary heart disease

Fourteen and fifteen year olds in Northern Ireland are using cannabis daily

Prazosin shows promise for post traumatic stress disorder sleep disturbances

Protalix BioTherapeutics receives FDA approval to initiate a phase III trial of prGCD

Placebo effect in the pharmacologic treatment of patients with lower urinary tract symptoms

New automated test for gene mutations causing fragile X syndrome

Jefferson participates in global study to extend effectiveness of drug for Parkinson's

Genta Incorporated announces phase 3 trial of Genasense in patients with advanced melanoma

The true value of herbs and spices on health

Drains increase harm without providing any benefit for patients undergoing open cholecystectomy

Study evaluates whether dipyrone is effective and safe for acute primary headaches

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News